Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1972 Sep;6(3):248–254. doi: 10.1128/iai.6.3.248-254.1972

Identification of Different Measles Virus-Specific Antibodies in the Serum and Cerebrospinal Fluid from Patients with Subacute Sclerosing Panencephalitis and Multiple Sclerosis 1

Aimo A Salmi 1,2, Erling Norrby 1,2, Martin Panelius 1,2
PMCID: PMC422523  PMID: 4629257

Abstract

Matched serum and cerebrospinal fluid (CSF) samples from eight cases of subacute sclerosing panencephalitis (SSPE) and 15 cases of multiple sclerosis (MS) were characterized in neutralization, hemolysis-inhibition (HLI), hemagglutination-inhibition (HI) with Tween 80—ether-treated antigen, complement-fixation (CF), and immunodiffusion tests. CF tests were carried out with crude virus material, purified nucleocapsids, and small particle hemagglutinin as antigens. A certain diversity in the relative content of antibodies against different virus products in various sera was found. There was a high degree of correlation between titers of neutralizing and HLI antibodies, but a less strict correlation between titers of HLI and HI antibodies. Serum samples from two cases of MS and one case of SSPE contained high titers of HLI and neutralizing antibodies in the presence of only low titers of HI antibodies demonstrable with Tween 80—ether-treated antigen. The major fraction of antibodies detected in CF and immunodiffusion tests reacted with nucleocapsids. There was a tendency of nucleocapsid CF antibody titers, as compared to neutralization and HLI antibody titers, to be higher in samples from patients with SSPE than from cases of MS. No significant differences were found between antibody titers recorded in neutralization, HLI, and HI tests carried out with two different measles virus strains, Edmonston and a strain (LEC) derived from a case of SSPE. Comparison of antibodies against measles virus products and, as a reference, against a group-specific vertex capsomer antigen of adenovirus in matched serum and CSF samples revealed a production of measles virus-specific antibodies within the central nervous system of all cases of SSPE and 8 out of 15 cases of MS.

Full text

PDF
248

Images in this article

251Image
on p.251

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS J. M., IMAGAWA D. T. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med. 1962 Dec;111:562–566. doi: 10.3181/00379727-111-27855. [DOI] [PubMed] [Google Scholar]
  2. Adams J. M., Brooks M. B., Fisher E. D., Tyler C. S. Measles antibodies in patients with multiple sclerosis and with other neurological and nonneurological diseases. Neurology. 1970 Oct;20(10):1039–1042. doi: 10.1212/wnl.20.10.1039. [DOI] [PubMed] [Google Scholar]
  3. Adams J. M. Measles antibodies in patients with multiple sclerosis. Neurology. 1967 Jul;17(7):707–passim. doi: 10.1212/wnl.17.7.707. [DOI] [PubMed] [Google Scholar]
  4. Barbanti-Brodano G., Oyanagi S., Katz M., Koprowski H. Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med. 1970 May;134(1):230–236. doi: 10.3181/00379727-134-34765. [DOI] [PubMed] [Google Scholar]
  5. Brody J. A., Sever J. L., Henson T. E. Virus antibody titers in multiple sclerosis patients, siblings, and controls. JAMA. 1971 May 31;216(9):1441–1446. [PubMed] [Google Scholar]
  6. Brown P., Cathala F., Gajdusek D. C., Gibbs C. J., Jr Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis. Proc Soc Exp Biol Med. 1971 Jul;137(3):956–961. doi: 10.3181/00379727-137-35704. [DOI] [PubMed] [Google Scholar]
  7. Connolly J. H. Additional data on measles virus antibody and antigen in subacute sclerosing panencephalitis. Neurology. 1968 Jan;18(1 Pt 2):87–90. doi: 10.1212/wnl.18.1_part_2.087. [DOI] [PubMed] [Google Scholar]
  8. Connolly J. H., Allen I. V., Hurwitz L. J., Millar J. H. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet. 1967 Mar 11;1(7489):542–544. doi: 10.1016/s0140-6736(67)92117-4. [DOI] [PubMed] [Google Scholar]
  9. Henson T. E., Brody J. A., Sever J. L., Dyken M. L., Cannon J. Measles antibody titers in multiple sclerosis patients, siblings, and controls. JAMA. 1970 Mar 23;211(12):1985–1988. [PubMed] [Google Scholar]
  10. Horta-Barbosa L., Hamilton R., Wittig B., Fuccillo D. A., Sever J. L., Vernon M. L. Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies. Science. 1971 Aug 27;173(3999):840–841. doi: 10.1126/science.173.3999.840. [DOI] [PubMed] [Google Scholar]
  11. Millar J. H., Fraser K. B., Haire M., Connolly J. H., Shirodaria P. V., Hadden D. S. Immunoglobulin M specific for measles and mumps in multiple sclerosis. Br Med J. 1971 May 15;2(5758):378–380. doi: 10.1136/bmj.2.5758.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Norrby E., Gollmar Y. Appearance and persistence of antibodies against different virus components after regular measles infections. Infect Immun. 1972 Sep;6(3):240–247. doi: 10.1128/iai.6.3.240-247.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Norrby E., Hammarskjöld B. Structural components of measles virus. Microbios. 1972 Jan;5(17):17–29. [PubMed] [Google Scholar]
  14. Norrby E., van der Veen J., Espmark A. A new serological technique for identification of adenovirus infections. Proc Soc Exp Biol Med. 1970 Jul;134(3):889–895. doi: 10.3181/00379727-134-34905. [DOI] [PubMed] [Google Scholar]
  15. PETTE E., KUWERT E. EVALUATION OF MULTIPLE SCLEROSIS SERA AGAINST MEASLES ANTIGEN IN THE COMPLEMENT FIXATION TEST. Arch Gesamte Virusforsch. 1965;16:141–147. doi: 10.1007/BF01253802. [DOI] [PubMed] [Google Scholar]
  16. Panelius M., Salmi A. A., Halonen P., Penttinen K. Measles antibodies detected with various techniques in sera of patients with multiple sclerosis. Acta Neurol Scand. 1971;47(3):315–330. doi: 10.1111/j.1600-0404.1971.tb07486.x. [DOI] [PubMed] [Google Scholar]
  17. Pettay O., Donner M., Halonen H., Palosuo T., Salmi A. Subacute sclerosing panencephalitis: preceding intellectual deterioration and deviant measles serology. J Infect Dis. 1971 Nov;124(5):439–444. doi: 10.1093/infdis/124.5.439. [DOI] [PubMed] [Google Scholar]
  18. Ross C. A., Lenman J. A., Melville I. D. Virus antibody levels in multiple sclerosis. Br Med J. 1969 Aug 30;3(5669):512–513. doi: 10.1136/bmj.3.5669.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SIBLEY W. A., FOLEY J. M. MEASLES ANTIBODIES IN MULTIPLE SCLEROSIS. Trans Am Neurol Assoc. 1963;88:277–281. [PubMed] [Google Scholar]
  20. Salmi A. A. Gel precipitation reactions between alkaline extracted rubella antigens and human sera. Acta Pathol Microbiol Scand. 1969;76(2):271–278. doi: 10.1111/j.1699-0463.1969.tb03257.x. [DOI] [PubMed] [Google Scholar]
  21. Salmi A. A., Panelius M., Halonen P., Rinne U. K., Penttinen K. Measles virus antibody in cerebrospinal fluids from patients with multiple sclerosis. Br Med J. 1972 Feb 19;1(5798):477–479. doi: 10.1136/bmj.1.5798.477. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES